Neuropeptide Y associated with asthma in young adults

Neuropeptides

Volumn 59, Issue , 2016, Pages 117-121

  Lu, Yanxia ^a   Andiappan, Anand Kumar ^b   Lee, Bernett ^b   Ho, Roger ^c   Lim, Tow Keang ^d   Kuan, Win Sen ^e   Goh, Daniel Yam Thiam ^c   Mahadevan, Malcolm ^e   Sim, Tiong Beng ^e   Wang, De Yun ^f   Van Bever, Hugo P S ^c   Rotzschke, Olaf ^b   Larbi, Anis ^b   Ng, Tze Pin ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b AGENCY FOR SCIENCE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adiposity; Asthma control; Neuropeptide Y polymorphism

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GENOMIC DNA; INTERLEUKIN 6; NEUROPEPTIDE Y;

ADULT; ARTICLE; ASTHMA; BODY MASS; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MORBIDITY; NEUROENDOCRINE SYSTEM; OBESITY; PATIENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; BLOOD; COMORBIDITY; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM;

ADIPONECTIN; ADIPOSITY; ADULT; ASTHMA; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEUROPEPTIDE Y; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; YOUNG ADULT;

EID: 84979687691     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2016.07.003     Document Type: Article

References (39)

1. Aldrich, M.C., Rodriguez-Santana, J.R., Rodriguez-Cintron, W., Beckman, K., Eng, C., Avila, P.C., Burchard, E.G., Genetic variation in neuropeptide Y NPY gene is associated with asthma and asthma severity, D21. Genetics of Airway Diseases II, 2009, American Thoracic Society, A5431.
2. Beuther, D.A., Sutherland, E.R., Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med. 175 (2007), 661–666.
3. Bray, M.S., Boerwinkle, E., Hanis, C.L., Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes. Res. 8 (2000), 219–226.
4. Capon, F., Allen, M.H., Ameen, M., Burden, A.D., Tillman, D., Barker, J.N., Trembath, R.C., A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum. Mol. Genet. 13 (2004), 2361–2368.
5. Celedon, J.C., Kolls, J.K., An innate link between obesity and asthma. Nat. Med. 20 (2014), 19–20.
6. Chen, Y.C., Dong, G.H., Lin, K.C., Lee, Y.L., Gender difference of childhood overweight and obesity in predicting the risk of incident asthma: a systematic review and meta-analysis. Obes. Rev. 14 (2013), 222–231.
7. Ding, B., Bertilsson, L., Wahlestedt, C., The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population. J. Clin. Pharm. Ther. 27 (2002), 211–212.
8. Groneberg, D.A., Folkerts, G., Peiser, C., Chung, K.F., Fischer, A., Neuropeptide Y (NPY). Pulm. Pharmacol. Ther. 17 (2004), 173–180.
9. Guillod-Maximin, E., Roy, A.F., Vacher, C.M., Aubourg, A., Bailleux, V., Lorsignol, A., Penicaud, L., Parquet, M., Taouis, M., Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J. Endocrinol. 200 (2009), 93–105.
10. Hsieh, Y.S., Chen, P.N., Yu, C.H., Liao, J.M., Kuo, D.Y., The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats. Mol. Brain, 6, 2013, 46.
11. Itokawa, M., Arai, M., Kato, S., Ogata, Y., Furukawa, A., Haga, S., Ujike, H., Sora, I., Ikeda, K., Yoshikawa, T., Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci. Lett. 347 (2003), 202–204.
12. Jaakkola, U., Kallio, J., Heine, R.J., Nijpels, G., T.H., L.M., Maassen, J.A., Bouter, L.M., Stehouwer, C.D., Dekker, J.M., Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study. Eur. J. Clin. Nutr. 63 (2009), 150–152.
13. Jaakkola, U., Kakko, T., Juonala, M., Lehtimaki, T., Viikari, J., Jaaskelainen, A.E., Mononen, N., Kahonen, M., Koskinen, T., Keltikangas-Jarvinen, L., Raitakari, O., Kallio, J., Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects—the cardiovascular risk in young Finns study. Neuropeptides 46 (2012), 321–328.
14. Karvonen, M.K., Pesonen, U., Koulu, M., Niskanen, L., Laakso, M., Rissanen, A., Dekker, J.M., Hart, L.M., Valve, R., Uusitupa, M.I., Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4 (1998), 1434–1437.
15. Kattan, M., Kumar, R., Bloomberg, G.R., Mitchell, H.E., Calatroni, A., Gergen, P.J., Kercsmar, C.M., Visness, C.M., Matsui, E.C., Steinbach, S.F., Szefler, S.J., Sorkness, C.A., Morgan, W.J., Teach, S.J., Gan, V.N., Asthma control, adiposity, and adipokines among inner-city adolescents. J. Allergy Clin. Immunol. 125 (2010), 584–592.
16. Kuo, L.E., Kitlinska, J.B., Tilan, J.U., Li, L., Baker, S.B., Johnson, M.D., Lee, E.W., Burnett, M.S., Fricke, S.T., Kvetnansky, R., Herzog, H., Zukowska, Z., Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13 (2007), 803–811.
17. Lappalainen, J., Kranzler, H.R., Malison, R., Price, L.H., Van Dyck, C., Rosenheck, R.A., Cramer, J., Southwick, S., Charney, D., Krystal, J., Gelernter, J., A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 59 (2002), 825–831.
18. Li, A.M., Chan, D., Wong, E., Yin, J., Nelson, E.A., Fok, T.F., The effects of obesity on pulmonary function. Arch. Dis. Child. 88 (2003), 361–363.
19. Lu, Y., Ho, R., Lim, T.K., Kuan, W.S., Goh, D.Y., Mahadevan, M., Sim, T.B., Van Bever, H.P., Larbi, A., Ng, T.P., Neuropeptide Y may mediate psychological stress and enhance TH2 inflammatory response in asthma. J. Allergy Clin. Immunol. 135 (2015), 1061–1063.
20. Makinde, T.O., Steininger, R., Agrawal, D.K., NPY and NPY receptors in airway structural and inflammatory cells in allergic asthma. Exp. Mol. Pathol. 94 (2013), 45–50.
21. Makino, K., Kataoka, Y., Hirakawa, Y., Ikeda, A., Yamauchi, A., Oishi, R., A leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population. J. Clin. Pharm. Ther. 26 (2001), 201–203.
22. Maniscalco, M., Zedda, A., Faraone, S., Cerbone, M.R., Cristiano, S., Giardiello, C., Sofia, M., Weight loss and asthma control in severely obese asthmatic females. Respir. Med. 102 (2008), 102–108.
23. McLachlan, C.R., Poulton, R., Car, G., Cowan, J., Filsell, S., Greene, J.M., Taylor, D.R., Welch, D., Williamson, A., Sears, M.R., Hancox, R.J., Adiposity, asthma, and airway inflammation. J. Allergy Clin. Immunol. 119 (2007), 634–639.
24. Mickey, B.J., Zhou, Z., Heitzeg, M.M., Heinz, E., Hodgkinson, C.A., Hsu, D.T., Langenecker, S.A., Love, T.M., Pecina, M., Shafir, T., Stohler, C.S., Goldman, D., Zubieta, J.K., Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch. Gen. Psychiatry 68 (2011), 158–166.
25. Ministry of Health, National Health Surveillance Survey 2007. https://www.moh.gov.sg/content/dam/moh_web/Publications/Reports/2009/nhss2007.pdf, 2009.
26. Mottagui-Tabar, S., Prince, J.A., Wahlestedt, C., Zhu, G., Goldman, D., Heilig, M., A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol. Clin. Exp. Res. 29 (2005), 702–707.
27. Rastogi, D., Canfield, S.M., Andrade, A., Isasi, C.R., Hall, C.B., Rubinstein, A., Arens, R., Obesity-associated asthma in children: a distinct entity. Chest 141 (2012), 895–905.
28. Shah, S.H., Freedman, N.J., Zhang, L., Crosslin, D.R., Stone, D.H., Haynes, C., Johnson, J., Nelson, S., Wang, L., Connelly, J.J., Muehlbauer, M., Ginsburg, G.S., Crossman, D.C., Jones, C.J., Vance, J., Sketch, M.H., Granger, C.B., Newgard, C.B., Gregory, S.G., Goldschmidt-Clermont, P.J., Kraus, W.E., Hauser, E.R., Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet., 5, 2009, e1000318.
29. Sood, A., Ford, E.S., Camargo, C.A., Association between leptin and asthma in adults. Thorax 61 (2006), 300–305.
30. Stenius-Aarniala, B., Poussa, T., Kvarnstrom, J., Gronlund, E.L., Ylikahri, M., Mustajoki, P., Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 320 (2000), 827–832.
31. Tan, N.C., Nguyen, H.V., Lye, W.K., Sankari, U., Nadkarni, N.V., Trends and predictors of asthma costs: results from a 10-year longitudinal study. Eur. Respir. J. 47 (2016), 801–809.
32. Thangaratnarajah, C., Dinger, K., Vohlen, C., Nawabi, J., Lopez, E.G., Dobner, J., Nüsken, K.D., Hoersten, S.V., Dötsch, J., Alejandre Alcazar, M.A., Novel NPY-mediated migratory effect on pulmonary fibroblasts and on IL-6 expression is related to accelerated lung growth after intrauterine growth restriction. Neuropeptides 55 (2016), 11–12.
33. Thomas, P.D., Kejariwal, A., Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15398–15403.
34. Vahatalo, L.H., Ruohonen, S.T., Ailanen, L., Savontaus, E., Neuropeptide Y in noradrenergic neurons induces obesity in transgenic mouse models. Neuropeptides 55 (2016), 31–37.
35. Wang, Y., Yang, Y., Hui, L., Tie, C., Li, F., Xu, Z.Q., Wang, C., A neuropeptide Y variant (rs16139) associated with major depressive disorder in replicate samples from Chinese Han population. PLoS One, 8, 2013, e57042.
36. Weiss, S.T., Shore, S., Obesity and asthma: directions for research. Am. J. Respir. Crit. Care Med. 169 (2004), 963–968.
37. Yu, J.T., Yu, N.N., Gao, S.S., Song, J.H., Ma, T., Wang, N.D., Tang, Y.C., Zhang, N., Tan, L., Neuropeptide Y polymorphisms and ischemic stroke in Chinese population. Clin. Chim. Acta 411 (2010), 242–245.
38. Zhang, K., Rao, F., Miramontes-Gonzalez, J.P., Hightower, C.M., Vaught, B., Chen, Y., Greenwood, T.A., Schork, A.J., Wang, L., Mahata, M., Stridsberg, M., Khandrika, S., Biswas, N., Fung, M.M., Waalen, J., Middelberg, R.P., Heath, A.C., Montgomery, G.W., Martin, N.G., Whitfield, J.B., Baker, D.G., Schork, N.J., Nievergelt, C.M., O'Connor, D.T., Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses. J. Am. Coll. Cardiol. 60 (2012), 1678–1689.
39. Zhou, Z., Zhu, G., Hariri, A.R., Enoch, M.A., Scott, D., Sinha, R., Virkkunen, M., Mash, D.C., Lipsky, R.H., Hu, X.Z., Hodgkinson, C.A., Xu, K., Buzas, B., Yuan, Q., Shen, P.H., Ferrell, R.E., Manuck, S.B., Brown, S.M., Hauger, R.L., Stohler, C.S., Zubieta, J.K., Goldman, D., Genetic variation in human NPY expression affects stress response and emotion. Nature 452 (2008), 997–1001.